Webinar: Scalable strategies for dual production of MSC and their derived EV

We would like to invite you to join our upcoming webinar, “Scalable Strategies for Dual Production of MSC and Their Derived Extracellular Vesicles (EVs).” This session will focus on recent advancements in scalable MSC and EV production systems and is intended for professionals in cell therapy and regenerative medicine.

Webinar Topics

Dr. Teresa Mendes from the iBB Group will present a series of approaches developed by her team, addressing:

• MSC Expansion in Vertical Wheel Reactors – Insights into expanding MSC from various tissue sources.
• MSC and EV Production with HPL GI EV-Depleted Formulation in Spinner Flasks – A look at formulation optimization for effective production.
• Manufacturing of MSC and EV in a Controlled Stirred-T

About the Speaker

Dr. Teresa Mendes has a PhD in Bioengineering and a background in molecular biology, specializing in 3D disease models and precision medicine. Her current research aims to improve culture systems for cell therapy applications, and she will provide practical insights into scalable MSC and EV production techniques.

• Discount: Webinar attendees will receive a 20% discount on AventaCell products.
• Certificate: A Certificate of Attendance will be available upon request.

Register Now

About AventaCell BioMedical Corp.

AventaCell BioMedical Corp. is a leader in human-derived products for cell culture and tissue regeneration, with a focus on serum-free solutions for translational research. The Helios Bioscience product line supports the efficient expansion of various cell types, including MSCs and immunocells, essential for regenerative medicine research.